Analysen zu RELX PLC (ex Reed Elsevier)
| 10.12.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 09.12.25 | RELX Buy | Deutsche Bank AG | |
| 05.11.25 | RELX Outperform | Bernstein Research | |
| 24.10.25 | RELX Hold | Deutsche Bank AG | |
| 21.10.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | RELX Buy | UBS AG | |
| 11.09.25 | RELX Outperform | Bernstein Research | |
| 08.09.25 | RELX Outperform | Bernstein Research | |
| 28.07.25 | RELX Hold | Deutsche Bank AG | |
| 25.07.25 | RELX Overweight | Barclays Capital | |
| 25.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | RELX Buy | UBS AG | |
| 11.07.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 07.07.25 | RELX Buy | UBS AG | |
| 04.07.25 | RELX Overweight | Barclays Capital | |
| 04.07.25 | RELX Buy | Goldman Sachs Group Inc. | |
| 25.06.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | RELX Overweight | Barclays Capital | |
| 25.04.25 | RELX Hold | Deutsche Bank AG | |
| 09.04.25 | RELX Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | RELX Buy | Goldman Sachs Group Inc. | |
| 20.03.25 | RELX Buy | UBS AG | |
| 14.03.25 | RELX Overweight | Barclays Capital | |
| 21.02.25 | RELX Buy | UBS AG | |
| 18.02.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 14.02.25 | RELX Hold | Deutsche Bank AG | |
| 14.02.25 | RELX Buy | UBS AG | |
| 14.02.25 | RELX Outperform | Bernstein Research | |
| 11.02.25 | RELX Outperform | Bernstein Research | |
| 21.01.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | RELX Outperform | Bernstein Research | |
| 11.12.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | RELX Buy | UBS AG | |
| 24.10.24 | RELX Outperform | Bernstein Research | |
| 10.10.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 26.07.24 | RELX Buy | UBS AG | |
| 17.07.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 28.06.24 | RELX Equal Weight | Barclays Capital | |
| 14.05.24 | RELX Buy | UBS AG | |
| 25.04.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | RELX Buy | Goldman Sachs Group Inc. | |
| 25.04.24 | RELX Buy | UBS AG | |
| 18.04.24 | RELX Buy | UBS AG | |
| 11.04.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 01.03.24 | RELX Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.02.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | RELX Buy | UBS AG | |
| 29.01.24 | RELX Equal Weight | Barclays Capital | |
| 22.01.24 | RELX Buy | UBS AG |
Aktuelle Aktienanalysen
| 12:26 | Volvo AB Buy | UBS AG | |
| 12:25 | Schneider Electric Buy | UBS AG | |
| 12:24 | Symrise Equal Weight | Barclays Capital | |
| 12:23 | Ahold Delhaize Underweight | JP Morgan Chase & Co. | |
| 12:18 | Carl Zeiss Meditec Halten | DZ BANK | |
| 11:33 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11:25 | BASF Kaufen | DZ BANK | |
| 10:14 | Michelin Outperform | Bernstein Research | |
| 09:58 | Sanofi Buy | Deutsche Bank AG | |
| 09:57 | L'Oréal Sell | Deutsche Bank AG | |
| 09:55 | GSK Hold | Deutsche Bank AG | |
| 09:55 | AstraZeneca Sell | Deutsche Bank AG | |
| 09:54 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09:52 | Novartis Buy | Deutsche Bank AG | |
| 09:38 | DEUTZ Buy | Warburg Research | |
| 09:38 | KION GROUP Buy | UBS AG | |
| 09:36 | WACKER CHEMIE Sell | Deutsche Bank AG | |
| 09:35 | WACKER CHEMIE Buy | UBS AG | |
| 09:35 | K+S Sell | UBS AG | |
| 09:34 | Evonik Neutral | UBS AG | |
| 09:33 | GEA Buy | UBS AG | |
| 09:32 | Daimler Truck Neutral | UBS AG | |
| 08:50 | RWE Buy | Deutsche Bank AG | |
| 08:17 | LANXESS Sell | UBS AG | |
| 07:44 | Nike Outperform | Bernstein Research | |
| 07:43 | adidas Outperform | Bernstein Research | |
| 07:39 | Fresenius Buy | Jefferies & Company Inc. | |
| 07:36 | Fresenius Overweight | JP Morgan Chase & Co. | |
| 07:34 | Ferrari Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07:32 | Airbus Overweight | Barclays Capital | |
| 07:31 | Fresenius Overweight | Barclays Capital | |
| 06:40 | Ferrari Outperform | RBC Capital Markets | |
| 15.12.25 | arGEN-X Buy | Jefferies & Company Inc. | |
| 15.12.25 | OMV Underweight | Barclays Capital | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 15.12.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 15.12.25 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 15.12.25 | arGEN-X Neutral | UBS AG | |
| 15.12.25 | Nestlé Neutral | UBS AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 15.12.25 | Sanofi Buy | UBS AG | |
| 15.12.25 | Sanofi Overweight | Barclays Capital | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | UBS Buy | Deutsche Bank AG | |
| 15.12.25 | Ströer Buy | Warburg Research | |
| 15.12.25 | Roche Hold | Deutsche Bank AG | |
| 15.12.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 15.12.25 | Polytec kaufen | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.